How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
Masana L, Plana N, Pérez-Calahorra S, Ibarretxe D, Lamiquiz-Moneo I, Pedro-Botet J, Suárez-Tembra M, Valdivielso P, Ortega E, Civeira F; Dyslipidemia Registry of the Spanish Arteriosclerosis Society.
Masana L, et al. Among authors: plana n.
Atherosclerosis. 2017 Jul;262:107-112. doi: 10.1016/j.atherosclerosis.2017.05.013. Epub 2017 May 12.
Atherosclerosis. 2017.
PMID: 28531826